MIAMI--(BUSINESS WIRE)--Noven Pharmaceuticals, Inc. (NASDAQ:NOVN) today announced that Robert Strauss, Noven’s President, CEO & Chairman, is scheduled to provide an update on Noven’s business and prospects at the UBS Global Life Sciences Conference in New York City on Tuesday, September 25th at 8:00 a.m. ET. The public is invited to listen to the presentation live via webcast at www.noven.com, and a replay will be available for at least two weeks at the same site.
